Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury.

Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury.
复制标题

DOI:
10.1016/j.nbd.2010.09.020
复制
发表时间:
2011-02
影响因子:
6.1
通讯作者:
Graham, Steven H.
Graham, Steven H.
中科院分区:
医学1区
文献类型:
--
作者:
Liu, Hao;Li, Wenjin;Ahmad, Muzamil;Miller, Tricia M.;Rose, Marie E.;Poloyac, Samuel M.;Uechi, Guy;Balasubramani, Manimalha;Hickey, Robert W.;Graham, Steven H.

文献摘要

参考文献

被引文献

相似文献

环戊烯酮前列腺素,如15-脱氧前列腺素12,14-前列腺素J2(15-deoxy-Δ12,14-prostaglandin J2,15d-PGJ2),是一种活性前列腺素代谢产物,具有多种生物学效应,可能在神经系统疾病的发病机制中起重要作用。泛素C末端水解酶L1(UCH-L1)是一种脑特异性脱泛素酶,其功能异常与神经退行性疾病有关。我们报道了短暂性局灶性脑缺血后大鼠脑内四极杆细胞质谱仪(MS)检测到的[15d-PGJ2]升高,15d-PGJ2治疗可诱导泛素蛋白积聚,加重常氧和低氧原代神经元的细胞死亡。15D-PGJ2共价修饰UCH-L1并抑制其水解酶活性。药物抑制UCH-L1加重缺氧性神经元死亡,而TAT-UCH-L1融合蛋白转导保护神经元免受缺氧。这些研究表明,UCH-L1功能在缺氧性神经元死亡中起重要作用,卒中后CyPG的过量产生可能通过对UCH-L1的修饰和抑制而加重缺血性损伤。
Cyclopentenone prostaglandins (CyPGs), such as 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2), are active prostaglandin metabolites exerting a variety of biological effects that may be important in the pathogenesis of neurological diseases. Ubiquitin-C-terminal hydrolase L1 (UCH-L1) is a brain specific deubiquitinating enzyme whose aberrant function has been linked to neurodegenerative disorders. We report that [15d-PGJ2] detected by quadrapole mass spectrometry (MS) increases in rat brain after temporary focal ischemia, and that treatment with 15d-PGJ2 induces accumulation of ubiquitinated proteins and exacerbates cell death in normoxic and hypoxic primary neurons. 15d-PGJ2 covalently modifies UCH-L1 and inhibits its hydrolase activity. Pharmacologic inhibition of UCH-L1 exacerbates hypoxic neuronal death while transduction with a TAT-UCH-L1 fusion protein protects neurons from hypoxia. These studies indicate UCH-L1 function is important in hypoxic neuronal death and excessive production of CyPGs after stroke may exacerbate ischemic injury by modification and inhibition of UCH-L1.
DOI: 10.1016/j.neuroscience.2005.05.015
发表时间: 2005-01-01
期刊: NEUROSCIENCE
影响因子: 3.3
作者:
Liu, CL;Ge, P;Hu, BR
通讯作者: Hu, BR
DOI: 10.1007/s00213-005-2195-5
发表时间: 2005-07-01
期刊: PSYCHOPHARMACOLOGY
影响因子: 3.4
作者:
García-Bueno, B;Madrigal, JLM;Leza, JC
通讯作者: Leza, JC
DOI: 10.1177/1073858408327809
发表时间: 2009-06
期刊: The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry
影响因子: --
作者:
Meller R
通讯作者: Meller R
DOI: 10.1074/jbc.m314124200
发表时间: 2004-03-26
影响因子: 4.8
作者:
Choi, J;Levey, AI;Li, L
通讯作者: Li, L
DOI: 10.1002/jnr.20346
发表时间: 2004-12-15
影响因子: 4.2
作者:
Li, ZM;Jansen, M;Figueiredo-Pereira, ME
通讯作者: Figueiredo-Pereira, ME